New

BUPRENORPHINE & NALOXONE SUBLINGUAL TABLETS

New

BUPRENORPHINE & NALOXONE SUBLINGUAL TABLETS

Overview

NDC #
Strength
Product/Case Size
NDC #
0121-1018-30
Strength
2 mg/0.5 mg
Product/Case Size
30 count/48 cs
NDC #
0121-2036-30
Strength
8 mg/2 mg
Product/Case Size
30 count/48 cs
0121-1018-30
2 mg/0.5 mg
30 count/48 cs
0121-2036-30
8 mg/2 mg
30 count/48 cs

Wholesale Ordering

NDC #
AmerisourceBergen
Cardinal
McKesson
Morris Dickson
NDC #
0121-1018-30
AmerisourceBergen
10282652
Cardinal
5869565
McKesson
2848752
Morris Dickson
TBD
NDC #
0121-2036-30
AmerisourceBergen
10282519
Cardinal
5869573
McKesson
2848745
Morris Dickson
TBD
0121-1018-30
10282652
5869565
2848752
TBD
0121-2036-30
10282519
5869573
2848745
TBD

Barcodes

NDC #
GTIN Product Barcode
GTIN Case Barcode
NDC #
0121-1018-30
GTIN Product Barcode
GTIN Case Barcode
NDC #
0121-2036-30
GTIN Product Barcode
GTIN Case Barcode
0121-1018-30
0121-2036-30
Download Barcode Brochure

Key Info

Compared to: SUBOXONE®

Free From:

Alcohol, dye, sugar

Rx or OTC:

Rx

Flavor:

Lemon, lime

Storage & Handling:

Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F).

Indications:

Buprenorphine and naloxone sublingual tablet contains buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist, and is indicated for the maintenance treatment of opioid dependence. Buprenorphine and naloxone sublingual tablet should be used as part of a treatment plan that includes counseling and psychosocial support. Please see full Prescribing Information for more information.